Apotex Health Pops 17% in Market Debut—A Sign the IPO Was Priced Too Low

Apotex Health opened at C$28 on June 10, 2026, up 17% from its C$24 IPO price. The jump shows that even top-of-range offerings can undershoot true demand. It raises a question for the next healthcare issuer: was this weak underwriter allocation, or real appetite from retail buyers?